May 8, 2020 / 9:46 PM / 20 days ago

BRIEF-U.S. FDA Approves Eli Lilly's Retevmo Capsules To Treat Three Types Of Tumors

May 8 (Reuters) - U.S. Food and Drug Administration:

* FDA APPROVES FIRST THERAPY FOR PATIENTS WITH LUNG AND THYROID CANCERS WITH A CERTAIN GENETIC MUTATION OR FUSION

* U.S. FDA - APPROVED RETEVMO CAPSULES TO TREAT THREE TYPES OF TUMORS

* U.S. FDA - FDA GRANTED APPROVAL OF RETEVMO TO LOXO ONCOLOGY, INC., A SUBSIDIARY OF ELI LILLY AND COMPANY Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below